Analysts Debunk Idea Of Scientist Shortage, Citing Defects In Current Economic Models

Peter House is chief analyst and director of the Division of Policy Research and Analysis at the National Science Foundation. In one corner of his 12th-floor office stands a bookcase filled with 30 years' work on public policy analysis and technical assessment. So it's somewhat surprising to the 54-year-old House that a single, 34-page unpublished paper written in 1989 and revised several times since then has attracted so much attention and made him the center of a sharp debate over whether the

Written byJeffrey Mervis
| 8 min read

Register for free to listen to this article
Listen with Speechify
0:00
8:00
Share

Peter House is chief analyst and director of the Division of Policy Research and Analysis at the National Science Foundation. In one corner of his 12th-floor office stands a bookcase filled with 30 years' work on public policy analysis and technical assessment. So it's somewhat surprising to the 54-year-old House that a single, 34-page unpublished paper written in 1989 and revised several times since then has attracted so much attention and made him the center of a sharp debate over whether the United States faces a shortage of scientists.

"We began with the fact that the population of college-age people has been declining since the mid-1980s, and will continue to drop until the middle of this decade," he explains. "Then we added in the fraction of Americans earning bachelor's degrees in the natural sciences and engineering [NS&E], a percentage that has been very stable over the past three decades."

From ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies